1. Salutaris Medical Devices developed a Radionuclide Brachytherapy Source tool for episcleral brachytherapy — the treatment of a specific type of eye cancer.
2. Rubraca is an ovarian cancer drug for women with a BRCA gene mutation who have already been treated with two or more chemotherapies.
3. Eucrisa is intended to treat mild to moderate cases of eczema.
4. Cepheid’s Xpert MRSA NxG test can detect methicillin-resistant Staphylococcus aureus in about one hour.
5. The AeroForm tissue expander system is used to stretch out breast tissue in preparation for a two-stage breast reconstruction following a mastectomy.
More articles on supply chain:
Salutaris’ brachytherapy device earns FDA market clearance
Champlain Valley Physicians Hospital undergoing critical blood shortage
Senate committee releases comprehensive report on high drug prices: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
